Literature DB >> 16856488

[Qualitative and quantitative determination of the main components of huanglianjiedu decoction by HPLC-UV/MS].

Jian Sun1, Ji-sheng Ma, Jin Jin, Huai-sheng Wang, Qing-hui Wen, Hong-gui Zhang, Qiu-li Zhou.   

Abstract

AIM: To establish a comprehensive HPLC analytical method of Huanglianjiedu decoction.
METHODS: This study was performed by HPLC-UV/MS to identify the chemical constituents of the whole and individual herbs of the "Huanglianjiedu decoction". Zorbax Extend C18 (150 mm x 4. 6 mm ID, 5 microm) column was used; the mobile phase was composed of acetonitrile (A) and water (B, with 0.5% acetic acid) with gradient elution; the flow rate was 1.0 mL x min(-1) and the column temperature was setup at 25 degrees C. The detection wavelength was 254 nm.
RESULTS: The chromatogram of Huanglianjiedu decoction showed 21 main peaks. Peaks 1, 2, 5 and 18 were from Gardenia jasminoides Ellis, Peaks 8, 13, 14, 15, 16, 17, 19 and 21 from Scutellaria baicalensis Georgi. While 10 from Coptis chinensis Franch and 20 from Phellodendron amurense Rupr., Peaks 3, 4, 6, 9, 11 and 12 came from them together. Peak 7 presented in the chromatograms of the herbs except Gardenia jasminoides Ellis. By comparison of the retention time, the on-line UV spectra and MS spectra, 11 peaks were identified as 5 (geniposide), 9 (jatrorrhizine), 10 (coptisine), 11 (palmatine), 12 (berberine), 13 (baicalin), 15 (oroxin A), 17 (wogonoside), 19 (baicalein), 20 (obaculactone), 21 (wogonin), then eight of them were quantified by HPLC-UV.
CONCLUSION: The method could represent the characteristics of Huanglianjiedu decoction, and it could be used to evaluate the quality and quantity of Huanglianjiedu decoction. It distinguished between Coptis chinensis Franch and Phellodendron amurense Rupr. by HPLC for the first time.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16856488

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  7 in total

1.  Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells.

Authors:  Ji-Won Lee; Ayumi Iwahashi; Shin-ichi Hasegawa; Takayuki Yonezawa; Won Bae Jeon; Byung-Yoon Cha; Kazuo Nagai; Je-Tae Woo
Journal:  J Nat Med       Date:  2011-06-09       Impact factor: 2.343

2.  Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state.

Authors:  Byeong-Hoon Lee; Kiramage Chathuranga; Md Bashir Uddin; Prasanna Weeratunga; Myun Soo Kim; Won-Kyung Cho; Hong Ik Kim; Jin Yeul Ma; Jong-Soo Lee
Journal:  J Microbiol       Date:  2017-05-28       Impact factor: 3.422

3.  Pseudogene MSTO2P Interacts with miR-128-3p to Regulate Coptisine Sensitivity of Non-Small-Cell Lung Cancer (NSCLC) through TGF-β Signaling and VEGFC.

Authors:  Minwei Gu; Xinlian Wang
Journal:  J Oncol       Date:  2022-06-26       Impact factor: 4.501

4.  Metabolic Interaction of the Active Constituents of Coptis chinensis in Human Liver Microsomes.

Authors:  Songcan Liu; Xinfeng Zhang; Furong Qiu; Ping Miao; Shujiao Shen; Leilei Zhu; Jin Zeng; Jian Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-06       Impact factor: 2.629

5.  Pharmacokinetic Differences of Wuji Pill Components in Normal and Chronic Visceral Hypersensitivity Irritable Bowel Syndrome Rats Attributable to Changes in Tight Junction and Transporters.

Authors:  Zipeng Gong; Qing Yang; Yajie Wang; Xiaogang Weng; Yujie Li; Yu Dong; Xiaoxin Zhu; Ying Chen
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

Review 6.  Effect of Rhizoma coptidis (Huang Lian) on Treating Diabetes Mellitus.

Authors:  Bing Pang; Xiao-Tong Yu; Qiang Zhou; Tian-Yu Zhao; Han Wang; Cheng-Juan Gu; Xiao-Lin Tong
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-05       Impact factor: 2.629

Review 7.  Huang-Lian Jie-Du decoction: a review on phytochemical, pharmacological and pharmacokinetic investigations.

Authors:  Yiyu Qi; Qichun Zhang; Huaxu Zhu
Journal:  Chin Med       Date:  2019-12-18       Impact factor: 5.455

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.